We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 6,153 results
  1. Role of Interphase FISH Assay on Air-Dried Smears in Identifying Specific Structural Chromosomal Abnormalities among Pediatric Patients with Acute Leukemias

    Leukemia-associated structural chromosomal abnormalities (SCA) can be identified either by karyoty** or interphase-fluorescence in-situ...

    Karthik Bommannan, Jhansi Rani Arumugam, ... Shirley Sundersingh in Indian Journal of Hematology and Blood Transfusion
    Article 26 September 2023
  2. Clinicopathologic features and genomic profiling of female axillary lymph node metastases from adenocarcinoma or poorly differentiated carcinoma of unknown primary

    Purpose

    Axillary lymph node metastases from adenocarcinoma or poorly differentiated carcinoma of unknown primary (CUPAx) is a rare disease in women....

    Liansha Tang, Yueting Zhu, ... Jiyan Liu in Journal of Cancer Research and Clinical Oncology
    Article Open access 15 May 2024
  3. A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify®

    Acute myeloid leukaemia (AML) is a rapidly fatal blood cancer that is characterised by the accumulation of immature myeloid cells in the blood and...

    Lin Ming Lee, Eleni G. Christodoulou, ... S. Tiong Ong in Oncogene
    Article 21 October 2022
  4. Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions

    Background

    Progressive multifocal leukoencephalopathy (PML) can rarely occur in Multiple Sclerosis (MS) patients undergoing dimethyl fumarate (DMF)...

    Elena Augusta Vola, Maria Petracca, ... Roberta Lanzillo in BMC Neurology
    Article Open access 05 April 2021
  5. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?

    Objectives

    Progressive multifocal leukoencephalopathy (PML) is a very rare and opportunistic encephalitis caused by JC polyomavirus that is linked to...

    Damien Roos-Weil, Nicolas Weiss, ... Valérie Pourcher in Journal of Neurology
    Article 30 January 2021
  6. Predictive values of plasma TNFα and IL-8 for intracranial hemorrhage in patients with acute promyelocytic leukemia

    In patients with acute promyelocytic leukemia (APL), intracranial hemorrhage (ICH), if not identified promptly, could be fatal. It is the leading...

    Fangyi Dong, Li Chen, ... Kankan Wang in Frontiers of Medicine
    Article 12 September 2022
  7. Progressive multifocal leukoencephalopathy in a patient with novel mutation in the RAC2 gene: a case report

    Background

    Progressive multifocal leukoencephalopathy is a rare demyelinating disease that is often secondary to lytic destruction of oligodendrocytes...

    Sima Bahrami, Saba Arshi, ... Sima Shokri in Journal of Medical Case Reports
    Article Open access 11 June 2022
  8. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease

    Progressive multifocal leukoencephalopathy (PML) is a devastating CNS infection caused by JC virus (JCV), a polyomavirus that commonly establishes...

    Irene Cortese, Daniel S. Reich, Avindra Nath in Nature Reviews Neurology
    Article 20 November 2020
  9. BRD4 interacts with PML/RARα in acute promyelocytic leukemia

    Bromodomain-containing 4 (BRD4) has been considered as an important requirement for disease maintenance and an attractive therapeutic target for...

    Qun Luo, Wanglong Deng, ... Ji Zhang in Frontiers of Medicine
    Article 14 December 2018
  10. Acute Promyelocytic Leukemia with t(2;3): An Unusual Additional Chromosomal Abnormality

    Acute promyelocytic leukemia is a distinct subset of acute myeloid leukemia with characteristic clinical, morphological and genetic features. The...

    Smeeta Gajendra, Anil Kumar Yadav, Manorama Bhargava in Indian Journal of Hematology and Blood Transfusion
    Article 10 July 2021
  11. PML with natalizumab

    Article 20 April 2019
  12. Progressive multifocal leukoencephalopathy in multiple myeloma. A literature review and lessons to learn

    Progressive multifocal leukoencephalopathy (PML) is a rare opportunistic infection with high mortality rate usually seen in the context of...

    Ioannis Koutsavlis in Annals of Hematology
    Article 03 October 2020
  13. Case of acute promyelocytic leukemia with basophilic differentiation and an ETV6 mutation

    The translocation between chromosomes 15 and 17 t(15;17) at the promyelocytic leukemia (PML) and retinoic acid receptor alpha (RARA) is thought to be...

    Anima Ghimire, Jane Liesveld, ... John Bennett in Journal of Hematopathology
    Article 28 October 2021
  14. Clinical Improvement of Progressive Multifocal Leukoencephalopathy Following Pembrolizumab Infusion: a Case Report

    Progressive multifocal leukoencephalopathy (PML) is a rare opportunistic brain infection caused by the John Cunningham (JC) virus, the cardinal...

    Z. Togher, S. Fullam, ... C. McGuigan in SN Comprehensive Clinical Medicine
    Article 06 January 2021
  15. Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study

    Background

    Natalizumab (NAT) has a strong impact on disease activity of aggressive pediatric multiple sclerosis (MS), with no difference in safety...

    Damiano Baroncini, Angelo Ghezzi, ... Gabriella Coniglio in Neurological Sciences
    Article 04 July 2022
  16. Autoantibodies to speckled protein family in primary biliary cholangitis

    The autoantibody profile of primary biliary cholangitis (PBC) includes antinuclear antibodies (ANA) which are detectable by indirect...

    Alessandro Granito, Luigi Muratori, ... Paolo Muratori in Allergy, Asthma & Clinical Immunology
    Article Open access 31 March 2021
  17. Progressive multifokale Leukenzephalopathie – ein Update

    Progressive multifocal leukoencephalopathy (PML) is a disease of the central nervous system elicited by the JC polyomavirus (JCV) mainly in...

    T. Rempe, F. Leypoldt, ... T. Bartsch in DGNeurologie
    Article 11 August 2020
  18. STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells

    Stathmin 1 (STMN1) is a microtubule-destabilizing protein highly expressed in hematological malignancies and involved in proliferation and...

    Hugo Passos Vicari, Juan Luiz Coelho-Silva, ... João Agostinho Machado-Neto in Investigational New Drugs
    Article 27 November 2021
  19. All-trans Retinoic Acid, Arsenic Trioxide, and Anthracycline-based Chemotherapy Improves Outcome in Newly Diagnosed Acute Promyelocytic Leukemia Regardless of FLT3-ITD Mutation Status

    All-trans retinoic acid (ATRA) and pre-upfront arsenic trioxide (ATO) have revolutionized the therapy of acute promyelocytic leukemia (APL). However,...

    Lin-wei Xu, Yong-zhong Su, Hong-fang Tao in Current Medical Science
    Article 25 June 2021
Did you find what you were looking for? Share feedback.